Zofran Lawsuit Claims That Drug Caused Severe Birth Defects

November 13, 2015 – – ZofranLegal.com reports on the filing of another lawsuits against anti-nausea drug Zofran and manufacturer GlaxoSmithKline. This lawsuit was filed by a single mother from Illinois, who claimed that exposure to the drug while developing in utero caused her child to be born with severe birth defects. The lawsuit was filed in the United States District Court for the Southern District of Illinois under case number 3:15-cv-00769.

According to details within the complaint, the mother indicates that she was prescribed Zofran during her pregnancy in order to treat nausea associated with morning sickness. She took the drug during her first trimester, which, coincidentally is also when a fetus does much of its mouth, heart, and limb development. Several months later, the woman gave birth to a son with multiple birth defects.

Like millions of other women across the U.S., this mother was prescribed Zofran while pregnant to combat morning sickness. The drug, however, has never been approved by the FDA for safety or use on expectant mothers. The U.S. Food and Drug Administration specifically approved Zofran, instead, to treat individuals suffering from bouts of nausea and vomiting due to having undergone chemotherapy, radiation, or anesthesia.

After being exposed to the drug while his heart was developing in the womb, the woman’s child was born with a debilitating heart deformity: hypoplastic right heart syndrome. This means that the right side of the child’s heart was significantly underdeveloped, causing malformed valves and chambers that were unable to deliver fresh blood to the boy’s lungs. Additionally, the infant’s pulmonary valve was completely absent.

Physicians indicated that if the child was going to survive, he would need to undergo a pediatric heart transplant procedure fairly quickly, and the boy was given a donor heart.This story is not unlike many others which have recently been brought to light as additional lawsuits are filed. All commonly allege that exposure to zofran while developing in utero caused their babies to be born with a range of birth defects. Defects most commonly named include cleft lip and palate, atrial septal defect and ventricular septal defect, transposition of the greater vessels, tetralogy of fallot, clubfoot, and kidney defects.

Across the United States, as lawsuits against Zofran continue to be filed, the attorneys at Monheit Law are working to ensure that anyone who was prescribed Zofran while pregnant and subsequently gave birth to a child with defects is able to investigate their legal rights. These families and their children may be entitled to compensation. Monheit Law offers those involved free consultations.

For additional information on Zofran lawsuits or to ask questions, contact Attorney Michael Monheit by calling 877-620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60005422